Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Accelerating Antidepressant Response with Liothyronine or Pindolol in Major Depression
NCT00221494Phase 4Withdrawn
- Start
- Jan 2004
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Citalopram + Liothyronine, Citalopram + Pindolol and Citalopram + Placebo (3 arms). Planned start Jan 2004; status: withdrawn.
02
Drugs
liothyroninepindolol
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00221494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00221494.